#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Phaeochromocytoma Indolent systemic mastocytosis Small for dates baby Pouchitis Glomerulonephritis minimal lesion B-cell small lymphocytic lymphoma Craniocerebral injury Metastases to peritoneum Central nervous system neoplasm Immunodeficiency Scleroderma associated digital ulcer Mantle cell lymphoma recurrent Acute myeloid leukaemia recurrent Hypomagnesaemia Hypocalcaemia More trials…

    Learn about Rare Diseases

    Pelizaeus-Merzbacher disease – Diagnostics Epidermolysis bullosa Sarcoidosis – Life with Disease Cholangitis sclerosing – Life with Disease Breast angiosarcoma metastatic – Trials in Disease Medulloblastoma – Life with Disease Medulloblastoma – Trials in Disease Medulloblastoma recurrent Congenital nephrogenic diabetes insipidus Nodal marginal zone B-cell lymphoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rilpivirine ANXV Cinchocaine Hydrochloride Trospium Chloride Tiotropium Bromide Tildrakizumab Pp1493 Rasagiline Apocynin L-ALANINE Benzathine Benzylpenicillin Ulonivirine SALICYLIC ACID Pirtobrutinib Filgotinib Rbd4059 Cefuroxime Sodium Metamizole Sodium Monohydrate Sirolimus Eftrenonacog Alfa More therapies…

    Learn about Your Condition

    Breast cancer stage III Dizziness B-cell lymphoma recurrent Eosinophilic gastritis Diarrhoea Prodromal Alzheimer's disease Vertebrobasilar stroke Infant sedation Portal hypertension Cervix carcinoma recurrent Guttate psoriasis Langerhans' cell histiocytosis Systemic scleroderma Erythema migrans Hypertonic bladder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hospital Universitario Mutua Terrassa

Hospital Universitario Mutua Terrassa

Plaza del Dr. Robert 5, Terrassa, 08221, Spain

Want to learn more about this study or check if you can participate? Contact us.

  • INCA33890 With Standard Chemotherapy and Bevacizumab in First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Bevacizumab
    • Calcium Folinate
    • Fluorouracil
    Austria Belgium Denmark France Germany Italy +4

  • A Study of Linvoseltamab in Adult Patients with High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hypergammaglobulinaemia benign monoclonal
    • Plasma cell myeloma
    Investigated Drugs:
    • Dexamethasone Sodium Phosphate
    • Linvoseltamab
    • Dexamethasone
    Belgium France Ireland Italy Poland Spain

  • A study comparing odronextamab combined with chemotherapy versus rituximab combined with chemotherapy in adults with previously untreated follicular lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Odronextamab
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    Austria Belgium Czechia France Germany Italy +2

  • A Study Comparing Two Treatment Schedules of Venetoclax and Azacitidine in Adults with Newly Diagnosed Acute Myeloid Leukemia Not Suitable for Intensive Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Venetoclax
    • Azacitidine
    France Spain

  • A study comparing montelukast to placebo for reducing pain in patients with erosive osteoarthritis of the hands

    Recruiting

    3 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Montelukast
    Italy Portugal Spain

  • Study on Continuous vs. Intermittent Infusion of Ampicillin and Ceftriaxone for Patients with Enterococcus faecalis Infective Endocarditis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endocarditis enterococcal
    Investigated Drugs:
    • Ceftriaxone Sodium
    • Dalbavancin
    • Ampicillin Sodium
    Spain

  • Study Comparing Elranatamab, Daratumumab, and Lenalidomide with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Elranatamab
    • Daratumumab
    • Human Normal Immunoglobulin
    Austria Belgium Czechia Denmark Finland France +6

  • Study on Apixaban and Edoxaban for Preventing Stroke in Patients with Recent Perioperative Atrial Fibrillation After Noncardiac Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Haemorrhage
    • Cerebrovascular accident
    • Atrial fibrillation
    Investigated Drugs:
    • Dabigatran
    • Apixaban
    • Edoxaban
    Belgium Denmark Finland France Germany Greece +5

  • Study Comparing Elranatamab to Drug Combinations for Patients with Relapsed/Refractory Multiple Myeloma After Anti-CD38 Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Elranatamab
    • Carfilzomib
    • Elotuzumab
    Belgium Croatia Czechia Denmark Finland France +10

  • Study on Tranexamic Acid Oral Solution for Preventing Bleeding in Patients on Blood Thinners Undergoing Tooth Extraction

    Recruiting

    3 1
    Investigated Diseases:
    • Gingival bleeding
    • Haemorrhage prophylaxis
    Investigated Drugs:
    • Tranexamic Acid
    Croatia Hungary Romania Spain
1 2 3
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!